Receive CeQur updates and product news.

Please select your region:

CeQur has obtained a CE mark for PaQ®. We will begin a focused launch of the product in 2014 and expansion in 2015. If you are:

PaQ® is not cleared for use in the United States.

CeQur is fully aware of the growing prevalence of diabetes throughout the world and the immense need for a simple, discreet, basal and bolus insulin delivery device like PaQ®. If you are:

  • Interested in staying informed about CeQur and PaQ, or
  • A healthcare provider interested in becoming an early launch site or clinical investigator.
  • A healthcare provider interested in becoming a clinical investigator.

Please fill out the form below.

* denotes a required field